Zobrazeno 1 - 10
of 55
pro vyhledávání: '"L A, DYKSTRA"'
Autor:
K. E. Blethen, S. A. Sprowls, T. A. Arsiwala, C. P. Wolford, D. M. Panchal, R. A. Fladeland, M. J. Glass, L. P. Dykstra, B. N. Kielkowski, J. R. Blackburn, C. J. Andrick, P. R. Lockman
Publikováno v:
Radiation Oncology, Vol 18, Iss 1, Pp 1-10 (2023)
Abstract Background Approximately 20% of all cancer patients will develop brain metastases in their lifespan. The standard of care for patients with multiple brain metastases is whole-brain radiation therapy, which disrupts the blood–brain barrier.
Externí odkaz:
https://doaj.org/article/7f08f2d0d5344a3e825d1f58f3ee88b2
Publikováno v:
The Journal of Immunology. 152:5845-5852
The present study examined the role of macrophage-derived nitric oxide in the suppressive effect of in vivo morphine administration on Con A-stimulated proliferation of splenic lymphocytes in rats. The results showed that concentrations of nitrite ar
Autor:
L A, DYKSTRA
Publikováno v:
Journal of the American Veterinary Medical Association. 110(839)
Autor:
L A, DYKSTRA
Publikováno v:
The North American veterinarian. 27(11)
Autor:
R M, Allen, L A, Dykstra
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 298(1)
Data from rodent antinociception models indicate that N-methyl-D-aspartate (NMDA) receptor antagonists do not produce antinociception alone or potentiate morphine antinociception, but do attenuate the development of morphine tolerance. This study exa
Publikováno v:
Advances in experimental medicine and biology. 437
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 285(3)
The opioid agonists morphine, etorphine, buprenorphine and U50,488 were examined alone and in combination with the insurmountable opioid antagonist clocinnamox (C-CAM) in squirrel monkeys responding under a schedule of shock titration. In this proced
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(3)
This study was directed at determining whether morphine's immunomodulatory effects are mediated through the periaqueductal gray (PAG). The initial study showed that microinjection of morphine (0.0, 0.4, 4.0, or 40.0 micrograms/rat) into the lateral v
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 277(2)
The present study examined the involvement of the sympathetic nervous system and the hypothalamic-pituitary-adrenal axis in the immunomodulatory effects of acute morphine treatment in rats. Chlorisondamine, a ganglionic blocker, was used to assess th
Publikováno v:
The Journal of pharmacology and experimental therapeutics. 276(2)
The present study assessed the involvement of opioid receptors both in the central nervous system (CNS) and in the periphery (i.e., on immunocytes) in the immune alterations produced by acute morphine treatment in rats. The first experiment showed th